According to Amneal Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -1.96%. At the end of 2024 the company had an Operating Margin of 7.29%.
Year | Operating Margin | Change |
---|---|---|
2024 | 7.29% | 2.38% |
2023 | 7.12% | -275.44% |
2022 | -4.06% | -150.65% |
2021 | 8.01% | 44.79% |
2020 | 5.53% | -272.88% |
2019 | -3.20% | -10.05% |
2018 | -3.56% | -115.17% |
2017 | 23.45% | -11.6% |
2016 | 26.53% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -8,391.15% | 428,019.90% | ๐บ๐ธ USA |
![]() | -1.45% | -26.02% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.